NfL has been found to be significantly increased in acute COVID-19 patients when compared to HC, regardless of the severeness of the disease, and the presence of major neurological symptoms, such as encephalopathy [24, 87, 88]. This evidence concerns the gene NEFL and Encephalopathy.